Insights for clinical diagnostic indicators of virus and host in chronic hepatitis B infection
- PMID: 31954089
- DOI: 10.1111/jvh.13260
Insights for clinical diagnostic indicators of virus and host in chronic hepatitis B infection
Abstract
Covalently closed circular DNA (cccDNA), which is stably present in the nucleus of hepatocytes, is an important indicator for evaluating antiviral efficacy. Since cccDNA quantification requires an invasive procedure, serum biological markers that can effectively reflect the transcriptional activity of intrahepatic virus and the efficacy of treatment are required. Here, from the aspects of virus and host, we outline the focus of clinical research of HBV in recent years, including HBV RNA, empty virus, hepatitis B core-related antigen and changes in the immune response. We briefly discuss their significance in predicting disease activity and monitoring treatment response in chronic hepatitis B. On this basis, some issues worthy of attention in laboratory diagnosis are proposed.
Keywords: HBV RNA; chronic hepatitis B; covalently closed circular DNA; empty virus; laboratory diagnosis.
© 2020 John Wiley & Sons Ltd.
References
REFERENCES
-
- Liver EAftSot. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol. 2012;57(1):167-185.
-
- Liver EAftSot. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370-398.
-
- Terrault NA, Bzowej NH, Chang KM, et al. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63(1):261-283.
-
- Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560-1599.
-
- Hepatology CSo. Guidelines for the prevention and treatment of chronic hepatitis B (2015). J Pract Hepatol. 2016;19(3):1-18.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
